X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (418) 418
Publication (39) 39
Book Review (10) 10
Book Chapter (8) 8
Dissertation (4) 4
Magazine Article (3) 3
Book / eBook (2) 2
Conference Proceeding (2) 2
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
gleevec (306) 306
imatinib mesylate (248) 248
humans (239) 239
benzamides (186) 186
imatinib (136) 136
index medicus (101) 101
oncology (101) 101
male (99) 99
chronic myeloid-leukemia (88) 88
chronic myelogenous leukemia (85) 85
pyrimidines - therapeutic use (84) 84
antineoplastic agents - therapeutic use (82) 82
animals (81) 81
piperazines - therapeutic use (81) 81
female (76) 76
pyrimidines - pharmacology (74) 74
piperazines - pharmacology (68) 68
cancer (64) 64
middle aged (61) 61
protein-tyrosine kinases - antagonists & inhibitors (56) 56
sti571 (56) 56
adult (55) 55
tyrosine kinase inhibitor (54) 54
antineoplastic agents - pharmacology (53) 53
leukemia (53) 53
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (53) 53
bcr-abl (52) 52
pharmacology & pharmacy (52) 52
aged (51) 51
tyrosine kinase (49) 49
c-kit (46) 46
cell line, tumor (46) 46
mice (45) 45
chronic myeloid leukemia (44) 44
gastrointestinal stromal tumor (41) 41
glivec (39) 39
sti-571 (36) 36
antineoplastic agents (35) 35
gastrointestinal stromal tumors (34) 34
in-vitro (34) 34
antimitotic agents (33) 33
chemistry, analytical (33) 33
piperazines - adverse effects (33) 33
pyrimidines - adverse effects (33) 33
antineoplastic agents - adverse effects (32) 32
cell biology (32) 32
imatinib mesylate gleevec (32) 32
apoptosis (31) 31
biochemistry & molecular biology (31) 31
care and treatment (31) 31
research (31) 31
hematology (30) 30
therapy (30) 30
inhibitor (28) 28
tumors (28) 28
gist (27) 27
growth (27) 27
mesylate (27) 27
philadelphia-chromosome (27) 27
pyrimidines - administration & dosage (27) 27
quantification (27) 27
resistance (27) 27
abl tyrosine kinase (26) 26
analysis (26) 26
cml (26) 26
piperazines - administration & dosage (26) 26
biochemical research methods (25) 25
drug st1571 gleevec (25) 25
immunohistochemistry (25) 25
signal transduction (25) 25
gastrointestinal stromal tumors - drug therapy (24) 24
protein kinase inhibitors - therapeutic use (24) 24
cells (23) 23
expression (23) 23
protein kinase inhibitors - pharmacology (23) 23
cell proliferation - drug effects (22) 22
chemotherapy (22) 22
dose-response relationship, drug (22) 22
drug resistance, neoplasm (22) 22
mutation (22) 22
pharmacokinetics (22) 22
pyrimidines - pharmacokinetics (22) 22
tandem mass-spectrometry (22) 22
treatment outcome (22) 22
tyrosine (22) 22
pathology (21) 21
antineoplastic agents - administration & dosage (20) 20
hemic and lymphatic diseases (20) 20
pyrimidines - blood (20) 20
surgery (20) 20
apoptosis - drug effects (19) 19
gastrointestinal stromal tumors - pathology (19) 19
medicine & public health (19) 19
piperazines - blood (19) 19
piperazines - pharmacokinetics (19) 19
proteins (19) 19
acute lymphoblastic-leukemia (18) 18
biology (18) 18
drug resistance (18) 18
drug therapy (18) 18
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (416) 416
French (6) 6
Korean (5) 5
German (4) 4
Spanish (2) 2
Chinese (1) 1
Japanese (1) 1
Polish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2005, Volume 102, Issue 6, pp. 1992 - 1997
Journal Article
Xenobiotica, ISSN 0049-8254, 03/2016, Volume 46, Issue 3, pp. 278 - 287
Journal Article
Brazilian Journal of Pharmaceutical Sciences, ISSN 1984-8250, 2018, Volume 54, Issue 2
Gleevec (imatinib) is an antineoplastic chemotherapeutic agent used in the treatment of many types of cancer. The current study was conducted to examine the... 
Chemotherapy | Proanthocyandins | Gleevec/effects | Liver | Proliferation | Gleevec/imatinib | Apoptosis | DOXORUBICIN | P53 | AMETHOPTERIN | BCL-2 | L-CARNITINE | ANTIOXIDANT | Gleevec/Imatinib | IMATINIB | PHARMACOLOGY & PHARMACY | EXPRESSION
Journal Article
Journal of Basic and Clinical Physiology and Pharmacology, ISSN 0792-6855, 09/2018, Volume 29, Issue 5, pp. 437 - 446
Research in rare diseases has contributed substantially toward the current understanding in the pathophysiology of the common diseases. However, medical needs... 
rare diseases | Gleevec | orphan drug | ODA
Journal Article
by Wang, ZX and Wu, XJ and Yang, HP and Guo, XM
BOLETIN DE MALARIOLOGIA Y SALUD AMBIENTAL, ISSN 1690-4648, 2019, Volume 59, Issue 1, pp. 126 - 131
Gastrointestinal stromal tumors are the most common mesenchymaltumors of the gastrointestinal tract, which originate in the gastrointestinal tract and... 
INFECTIOUS DISEASES | Tumor Recurrence | MesenchymalTumors | Gleevec | Targeted Therapy | PARASITOLOGY
Journal Article
AMERICAN JOURNAL OF SURGERY, ISSN 0002-9610, 12/2003, Volume 186, Issue 6, pp. 665 - 669
Background: Imatinib mesylate (Gleevec) is being studied as adjuvant chemotherapy for the treatment of cKIT+ gastrointestinal stromal tumors (GISTs). Early... 
neoadjuvant | gastrointestinal stromal tumor | KIT | Gleevec | imatinib mesylate | surgery
Journal Article
2013, ISBN 1615190678, xiii, 303 p., [8] p. of plates
Book
Current opinion in oncology, ISSN 1040-8746, 7/2014, Volume 26, Issue 4, pp. 415 - 421
Journal Article
Korean Journal of Dermatology, ISSN 0494-4739, 06/2015, Volume 53, Issue 5, pp. 388 - 391
Journal Article
Cancer Treatment Reviews, ISSN 0305-7372, 2009, Volume 35, Issue 8, pp. 692 - 706
Summary In the recent years, eight tyrosine kinase inhibitors (TKIs) have been approved for cancer treatment and numerous are under investigation. These drugs... 
Hematology, Oncology and Palliative Medicine | Excretion | Absorption | Metabolism | Tyrosine kinase inhibitors | Distribution | Drug transporters and interactions | CHRONIC MYELOGENOUS LEUKEMIA | RENAL-CELL CARCINOMA | CHRONIC MYELOID-LEUKEMIA | ONCOLOGY | ACUTE LYMPHOBLASTIC-LEUKEMIA | CHRONIC MYELOCYTIC-LEUKEMIA | ADVANCED SOLID MALIGNANCIES | IMATINIB MESYLATE GLEEVEC | GASTROINTESTINAL STROMAL TUMORS | CEREBROSPINAL-FLUID PHARMACOKINETICS | CANCER RESISTANCE PROTEIN | Erlotinib Hydrochloride | Niacinamide - analogs & derivatives | Pyrroles - pharmacokinetics | Humans | Cytochrome P-450 Enzyme System - metabolism | Pyridines - pharmacokinetics | Quinazolines - pharmacokinetics | Biological Availability | Phenylurea Compounds | Antineoplastic Agents - administration & dosage | Intestinal Absorption | Thiazoles - pharmacokinetics | Antineoplastic Agents - metabolism | Tissue Distribution | Benzenesulfonates - pharmacokinetics | Drug Interactions | Antineoplastic Agents - pharmacokinetics | Antineoplastic Agents - pharmacology | Piperazines - pharmacokinetics | Protein Kinase Inhibitors - pharmacokinetics | Dasatinib | Administration, Oral | Imatinib Mesylate | Protein Kinase Inhibitors - blood | Protein Kinase Inhibitors - administration & dosage | Antineoplastic Agents - blood | Pyrimidines - pharmacokinetics | Indoles - pharmacokinetics | Protein Kinase Inhibitors - pharmacology | Benzamides | Protein Kinase Inhibitors - metabolism | Protein-Tyrosine Kinases - antagonists & inhibitors | Tyrosine | Care and treatment | Oncology, Experimental | Cytochrome P-450 | Physiological aspects | Phenols | Research | Phosphotransferases | Protein binding | Cancer | Index Medicus
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 02/2017, Volume 114, Issue 6, pp. 1389 - 1394
Journal Article
대한피부과학회지, ISSN 0494-4739, 2015, Volume 53, Issue 5, p. 388
Imatinib mesylate (Gleevecⓡ) is a small-molecule inhibitor that selectively inhibits the tyrosine kinase family, including mutated KIT oncoproteins in... 
Psoriasis | Imatinib mesylate | Gleevec | Gastrointestinal stromal tumor
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.